DD
Deniz Demircioglu
Icahn School of Medicine at Mount Sinai, Genome Institute of Singapore, National University of Singapore
0000-0001-7857-0407
Employment
-
Icahn School of Medicine at Mount Sinai Assistant Professor2023 - Present
-
Icahn School of Medicine at Mount Sinai Bioinformatician II2020 - Present
-
Genome Institute of Singapore Postdoctoral Fellow2019 - 2020
Education
-
National University of Singapore PhD2015 - 2020
-
Genome Institute of Singapore PhD2015 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (77)
- Figure S1 from De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways Save
- Data from De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways Save
- Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer Save
- Supplementary Table S9 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save
- Supplementary Table S8 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save
- Supplementary Table S7 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save
- Supplementary Table S6 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save
- Supplementary Table S5 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save
- Supplementary Table S4 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save
- Supplementary Table S3 from SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma Save